Neurogene (NGNE) Profit After Tax (2013 - 2026)

Neurogene's Profit After Tax history runs 14 years deep, the most recent figure standing at -$30.9 million for Q1 2026.

• Quarterly Profit After Tax fell 36.59% year-over-year to -$30.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$98.7 million (down 22.05% YoY) and the FY2025 annual result came in at -$90.4 million, down 20.3% from the prior year.
• Profit After Tax was -$30.9 million for Q1 2026 at Neurogene, down from -$24.8 million in the prior quarter.
• Across five years, Profit After Tax topped out at $13.7 million in Q4 2023 and bottomed at -$49.8 million in Q4 2022.
• A 5-year average of -$18.6 million and a median of -$18.5 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax surged 127.4% — and 2024, when it tumbled 242.92%.
• Neurogene's Profit After Tax stood at -$49.8 million in 2022, then surged by 127.4% to $13.7 million in 2023, then tumbled by 242.92% to -$19.5 million in 2024, then slipped by 27.09% to -$24.8 million in 2025, then slipped by 24.73% to -$30.9 million in 2026.
• Business Quant data shows NGNE's Profit After Tax at -$30.9 million in Q1 2026, -$24.8 million in Q4 2025, and -$21.0 million in Q3 2025.